Cineplex Stock Is a Buy, But Beware of This 1 Risk!

Cineplex stock is one of the top Canadian stocks to buy for its recovery potential. However, if you’re going to buy Cineplex, be aware of this one risk!

| More on:

After the initial fear wore after the market crash last year, investors quickly realized what excellent opportunities existed. For months now, investors have seen huge returns as stocks have rebounded from their lows and, in many cases, reached new highs. However, some stocks, like Cineplex (TSX:CGX), have been impacted far worse than any other.

So nearly a year and a half into the pandemic, Cineplex stock has been badly impacted. In some provinces, all of its locations remain completely closed.

Recovery stocks like Cineplex have lagged the market for some time as these businesses are way different from any other company.

Now, though, Cineplex stock has picked up some momentum and looks like it could finally be a buy. If you’re considering an investment in Cineplex stock, though, I’d be careful of this risk.

Buy Cineplex stock as a long-term investment

First and foremost, before you even consider buying Cineplex, make sure it’s for the right reasons, and you’re making a long-term investment.

You might be buying Cineplex stock for short-term gains and its potential to rally rapidly while it recovers. However, you should only consider that if it’s actually a stock, you’d own long term.

If things go south, which is entirely possible, you could be left holding it for a while. So if you’re trying to speculate on the stock price of Cineplex, you’re making the investment a lot riskier.

If you plan to hold the business for the long-term, though, then should negative impacts materialize, you can use the opportunity to double down on your position.

Why things could go south

The one main risk with an investment in Cineplex is the uncertainty factor we are still facing. We have seen plenty of times already, Cineplex’s recovery getting derailed. And while this time around seems to be different, it’s crucial to be mindful that we aren’t out of the woods yet.

We are getting really optimistic this time with vaccination rates rising. However, there is still a lot of uncertainty going forward. This uncertainty means that an investment in Cineplex stock still comes with significant risk, especially since it can be majorly affected by shutdowns and stay-at-home orders.

For some investors, though, the risk will be worth the reward. Every day we vaccinate more people, and case counts drop, that risk erodes slightly. So once you decide you’re comfortable buying Cineplex stock for the long run, then you can look at how much it’s worth today and whether or not you’d have to overpay for it.

Don’t overpay for Cineplex stock

Before the pandemic, when Cineplex was a high-quality business with plenty of future potential, the stock was being taken over at $34.

The trouble with buying Cineplex today is that it’s tough to gauge what it could recover too. But, because it’s nowhere near as strong as a position it as before the pandemic, it’s safe to say that $34 will be the best-case scenario for some time.

But with most analysts’ target price for Cineplex below its current market price, how much is the stock actually worth?

We don’t know what life after the pandemic will exactly look like and how much Cineplex’s businesses will recover, or how long it may take. Furthermore, its razor-thin margins could be impacted again.

So while Cineplex looks attractive and is certainly primed for a recovery rally, I’d certainly be careful not to overpay for the stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC.

More on Stocks for Beginners

engineer at wind farm
Energy Stocks

Invest $20,000 in This Dividend Stock for $100 in Monthly Passive Income

This dividend stock has it all – a strong outlook, monthly income, and even more to consider buying today.

Read more »

stocks climbing green bull market
Stocks for Beginners

3 TSX Stocks Soaring Higher With No Signs of Slowing

Don't ignore stocks just because they look like they're at a high price. Instead, see exactly why they've driven so…

Read more »

Middle aged man drinks coffee
Dividend Stocks

Here’s the Average TFSA Balance at Age 35 in Canada

At age 35, it might not seem like you need to be thinking about your future cash flow. But ideally,…

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

CPP Pensioners: Watch for These Important Updates

The CPP is an excellent tool for retirees, but be sure to stay on top of important updates like these.

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Stocks for Beginners

2 Top TSX Growth Stocks to Stash in a TFSA for Life

These two growth stocks may not be the top in the last month, but in the last few years, they…

Read more »

people relax on mountain ledge
Dividend Stocks

Invest $10,000 in This Dividend Stock for a Potential $4,781.70 in Total Returns

A dividend stock doesn't have to be risky, or without growth. And in the case of this one, the growth…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Turn a $15,000 TFSA Into $171,000

$15,000 may not seem like a lot, but over time that amount can balloon into serious cash.

Read more »

A worker uses a double monitor computer screen in an office.
Stocks for Beginners

Why I’d Buy Fairfax Financial Stock Even at Today’s Prices

Fairfax stock just keeps edging higher. But is it now too expensive, or can investors just look forward to even…

Read more »